ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)

SEC filing

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT · CIK 1787306

4 · Sep 17, 2026 · Director Welgus Howard G. sold 4,730 shares at $24.18/share ($114.4K); exercised options for 8,192 shares

Director Welgus Howard G. sold 4,730 shares at $24.18/share ($114.4K); exercised options for 8,192 shares

FORM 4

xslF345X06/wk-form4_1789675580.xmlSEC.gov

Graphics and non-inline formats (not embedded below).